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Supplementary figure 1. Differentiation of PMA-treated THP-1 and U937 cells. THP-1 and U937 cells (0.2*10 6 cells, 1ml, 12 well plates) were treated for 2 days with PMA ranging from 0.5 to 25 ng/ml and IL-1β mRNA, TNFα secretion and CD11c and CD14 surface expression were analysed. (A) IL-1β mRNA was quantified by RT-qPCR. The graphs show the mean +/-SEM (reported to 25 ng/ml PMA) of three independent experiments. The mean value (IL-1β transcripts per 2,000 EF1 transcripts) of the reference condition is indicated on top of the relevant bar. (B) TNFα was quantified by ELISA (R&D Systems) in the cell culture supernatant (mean +/-SD of biological duplicates from one experiment). (C) Cells were stained with FITC anti-CD11c (BD Biosciences), APC-Cy7 anti-CD14 (BioLegend), APC Annexin V (BioLegend) and propidium iodide (PI) (Sigma-Aldrich) and analyzed by flow cytometry. Cell debris were excluded, living cells (Annexin V-and PI-negative) were selected and CD11c-and CD14-positive populations were defined based on isotype control stainings. The graphs show the percentage of CD11c-or CD14-positive cells amongst living cells (mean +/-SD of biological duplicates from one experiment). 
